MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/20/1483/001  MenQuadfi   
EU/1/20/1483/002  MenQuadfi   
EU/1/20/1483/003  MenQuadfi   
EU/1/20/1483/004  MenQuadfi   
--¹ 
--¹ 
--¹ 
--¹ 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
--¹ 
--¹ 
One dose 0.5 mL contains: 
Neisseria meningitidis group A polysaccharide² 10 micrograms 
Neisseria meningitidis group C polysaccharide² 10 micrograms 
Neisseria meningitidis group Y polysaccharide² 10 micrograms 
Neisseria meningitidis group W polysaccharide² 10 micrograms 
²Conjugated to tetanus toxoid carrier protein 55 micrograms 
Intramuscular use  vial (glass) 
0.5 ml 
Intramuscular use  vial (glass) 
0.5 ml 
1 vial  
5 vials  
Intramuscular use  Vial (glass) 
0.5 ml 
Intramuscular use  vial (glass) 
0.5 ml 
1 vial+ 1 syringe + 
2 needles  
10 vials  
 
 
 
